Follow
Virender Kumar, Ph.D.
Virender Kumar, Ph.D.
University of Toledo Medical Center
Verified email at utoledo.edu
Title
Cited by
Cited by
Year
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Q Su, V Kumar, N Sud, RI Mahato
Advanced drug delivery reviews 129, 54-63, 2018
1182018
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
AK Chaudhary, G Mondal, V Kumar, K Kattel, RI Mahato
Cancer letters 402, 1-8, 2017
1052017
miRNA profiling in pancreatic cancer and restoration of chemosensitivity
S Singh, D Chitkara, V Kumar, SW Behrman, RI Mahato
Cancer letters 334 (2), 211-220, 2013
902013
Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer
V Kumar, G Mondal, P Slavik, S Rachagani, SK Batra, RI Mahato
Molecular pharmaceutics 12 (4), 1289-1298, 2015
862015
Challenges and recent advances in medulloblastoma therapy
V Kumar, V Kumar, T McGuire, DW Coulter, JG Sharp, RI Mahato
Trends in pharmacological sciences 38 (12), 1061-1084, 2017
772017
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
V Kumar, X Xin, J Ma, C Tan, N Osna, RI Mahato
Advanced drug delivery reviews 176, 113888, 2021
732021
Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
V Kumar, G Mondal, R Dutta, RI Mahato
Biomaterials 76, 144-156, 2016
692016
Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer
D Chitkara, S Singh, V Kumar, M Danquah, SW Behrman, N Kumar, ...
Molecular pharmaceutics 9 (8), 2350-2357, 2012
592012
EGFR-targeted polymeric mixed micelles carrying gemcitabine for treating pancreatic cancer
G Mondal, V Kumar, SK Shukla, PK Singh, RI Mahato
Biomacromolecules 17 (1), 301-313, 2016
522016
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
X Xin, V Kumar, F Lin, V Kumar, R Bhattarai, VR Bhatt, C Tan, RI Mahato
Science advances 6 (46), eabd6764, 2020
502020
Delivery and targeting of miRNAs for treating liver fibrosis
V Kumar, RI Mahato
Pharmaceutical research 32, 341-361, 2015
502015
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis
V Kumar, V Mundra, RI Mahato
Pharmaceutical research 31, 1158-1169, 2014
502014
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
V Kumar, V Mundra, Y Peng, Y Wang, C Tan, RI Mahato
Theranostics 8 (15), 4033, 2018
412018
Design of Hedgehog pathway inhibitors for cancer treatment
J Bariwal, V Kumar, Y Dong, RI Mahato
Medicinal research reviews 39 (3), 1137-1204, 2019
382019
Design, synthesis and biological evaluation of novel hedgehog inhibitors for treating pancreatic cancer
V Kumar, AK Chaudhary, Y Dong, HA Zhong, G Mondal, F Lin, V Kumar, ...
Scientific reports 7 (1), 1665, 2017
362017
Impact of miRNA-mRNA profiling and their correlation on medulloblastoma tumorigenesis
RIM Vinod Kumar, Virender Kumar, Amit Kumar Chaudhary, Donald W. Coulter ...
Molecular Therapy: Nucleic Acid, 2018
352018
ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice
Q Wang, V Kumar, F Lin, B Sethi, DW Coulter, TR McGuire, RI Mahato
Journal of controlled release 323, 463-474, 2020
332020
Organic nanocarriers for delivery and targeting of therapeutic agents for cancer treatment
Y Peng, J Bariwal, V Kumar, C Tan, RI Mahato
Advanced Therapeutics 3 (2), 1900136, 2020
282020
Biodistribution of self-assembling polymer–gemcitabine conjugate after systemic administration into orthotopic pancreatic tumor bearing mice
K Kattel, G Mondal, F Lin, V Kumar, RI Mahato
Molecular pharmaceutics 14 (5), 1365-1372, 2017
282017
Therapeutic Potential of OMe-PS-miR-29b1 for treating Liver Fibrosis
RIM Virender Kumar, Vinod Kumar, Jiangtao Luo
Molecular Therapy, 2018
242018
The system can't perform the operation now. Try again later.
Articles 1–20